 |
 |
|
|
|  PubMed
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
The Relationship between Blood Sugar Control and Cardiovascular Disease in Patients with Diabetes
21 September 2004 | Volume 141 Issue 6 | Page I-21
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.
The summary below is from the full report titled "Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus." It is in the 21 September 2004 issue of Annals of Internal Medicine (volume 141, pages 421-431). The authors are E. Selvin, S. Marinopoulos, G. Berkenblit, T. Rami, F.L. Brancati, N.R. Powe, and S. Hill Golden.
What is the problem and what is known about it so far?
Diabetes interferes with the body's ability to store energy from food. The pancreas makes a substance called insulin that helps the body to turn food into stored energy. Type 1 diabetes (juvenile diabetes) occurs when the pancreas stops making insulin. In type 2 diabetes (adult-onset diabetes), the body still makes insulin but cannot use it normally. In both cases, the result is high blood sugar levels. Over time, high blood sugar levels can lead to many complications, including blindness, kidney failure, nerve damage, and cardiovascular disease (heart disease and stroke). Fortunately, good care with diet, exercise, and medications to control blood sugar levels clearly prevents or delays the development of diabetes-related blindness, kidney failure, and nerve damage. The relationship between blood sugar control and cardiovascular disease is less clear. Glycosylated hemoglobin is a blood test that measures blood sugar control over the previous 3 months.
Why did the authors do this meta-analysis?
To summarize evidence from previous studies to determine the strength of the relationship between glycosylated hemoglobin levels and cardiovascular disease in patients with diabetes.
How did the authors do this meta-analysis?
The researchers searched the computerized database of the National Library of Medicine for studies related to glycosylated hemoglobin, diabetes, and cardiovascular disease. They included only studies that first measured glycosylated hemoglobin levels and then followed patients to see whether they developed cardiovascular disease. The authors used special statistical techniques to combine the information from the studies in order to more precisely estimate the relationship than would be possible in any single study by itself.
What did the authors find?
Of studies that met their requirements, the authors found 3 studies involving 1688 patients with type 1 diabetes and 10 studies involving 7435 patients with type 2 diabetes. When they combined the data from these studies, the researchers found that the risk for cardiovascular disease increased with increasing glycosylated hemoglobin levels. Higher levels means worse blood sugar control. The relationship was present and similar for both type 1 and type 2 diabetes.
What are the implications of the meta-analysis?
Poor control of blood sugar levels in people with type 1 or type 2 diabetes is associated with the development of cardiovascular disease. These findings suggest, but cannot prove, that improved blood sugar levels will decrease the chances that a person with diabetes will develop cardiovascular disease.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
Find additional patient-related information at:
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  Z. T. Bloomgarden Cardiovascular Disease, Neuropathy, and Retinopathy Diabetes Care, June 1, 2009; 32(6): e64 - e68. [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Kahn Glucose Control in Type 2 Diabetes: Still Worthwhile and Worth Pursuing JAMA, April 15, 2009; 301(15): 1590 - 1592. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Sherifali and Z. Punthakee To lower or not to lower? Making sense of the latest research on intensive glycaemic control and cardiovascular outcomes Evid. Based Med., April 1, 2009; 14(2): 34 - 37. [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Nuzum and T. Merz Macrovascular Complications of Diabetes Mellitus Journal of Pharmacy Practice, April 1, 2009; 22(2): 135 - 148. [Abstract] [PDF]
|
|
|
|
 |
|
 I. W Campbell Review: Durable glycaemia -- the promised land The British Journal of Diabetes & Vascular Disease, March 1, 2009; 9(2): 53 - 63. [Abstract] [PDF]
|
|
|
|
 |
|
 A. G. Rajapakse, X.-F. Ming, J. M. Carvas, and Z. Yang The hexosamine biosynthesis inhibitor azaserine prevents endothelial inflammation and dysfunction under hyperglycemic condition through antioxidant effects Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H815 - H822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Skyler, R. Bergenstal, R. O. Bonow, J. Buse, P. Deedwania, E. A.M. Gale, B. V. Howard, M. S. Kirkman, M. Kosiborod, P. Reaven, et al. Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association J. Am. Coll. Cardiol., January 20, 2009; 53(3): 298 - 304. [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Skyler, R. Bergenstal, R. O. Bonow, J. Buse, P. Deedwania, E. A.M. Gale, B. V. Howard, M. S. Kirkman, M. Kosiborod, P. Reaven, et al. Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association Circulation, January 20, 2009; 119(2): 351 - 357. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Sherifali and Z. Punthakee To lower or not to lower? Making sense of the latest research on intensive glycaemic control and cardiovascular outcomes Evid. Based Nurs., January 1, 2009; 12(1): 4 - 6. [Full Text] [PDF]
|
|
|
|
|
|
D. Sherifali Intensive glucose control did not prevent important complications in type 2 diabetes Evid. Based Nurs., January 1, 2009; 12(1): 12 - 13. [Full Text] [PDF]
|
|
|
|
|
|
J. S. Skyler, R. Bergenstal, R. O. Bonow, J. Buse, P. Deedwania, E. A.M. Gale, B. V. Howard, M. S. Kirkman, M. Kosiborod, P. Reaven, et al. Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association Diabetes Care, January 1, 2009; 32(1): 187 - 192. [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Sheehy, D. B. Coursin, and R. A. Gabbay Back to Wilson and Jungner: 10 Good Reasons to Screen for Type 2 Diabetes Mellitus Mayo Clin. Proc., January 1, 2009; 84(1): 38 - 42. [Full Text] [PDF]
|
|
|
|
|
|
American Diabetes Association Standards of Medical Care in Diabetes--2009 Diabetes Care, January 1, 2009; 32(Supplement_1): S13 - S61. [Full Text] [PDF]
|
|
|
|
|
|
X. Yang, G. T.C. Ko, W. Y. So, R. C.W. Ma, A. P.S. Kong, C. W.K. Lam, C. S. Ho, C.-C. Chow, P. C.Y. Tong, and J. C.N. Chan Additive Interaction of Hyperglycemia and Albuminuria on Risk of Ischemic Stroke in Type 2 Diabetes: Hong Kong Diabetes Registry Diabetes Care, December 1, 2008; 31(12): 2294 - 2300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kosiborod Blood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction Diabetes and Vascular Disease Research, November 1, 2008; 5(4): 269 - 275. [Abstract] [PDF]
|
|
|
|
 |
|
 W T. Cade Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting Physical Therapy, November 1, 2008; 88(11): 1322 - 1335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Selvin, S. Bolen, H.-C. Yeh, C. Wiley, L. M. Wilson, S. S. Marinopoulos, L. Feldman, J. Vassy, R. Wilson, E. B. Bass, et al. Cardiovascular Outcomes in Trials of Oral Diabetes Medications: A Systematic Review Arch Intern Med, October 27, 2008; 168(19): 2070 - 2080. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sander, K. Sander, and H. Poppert Review: Stroke in type 2 diabetes The British Journal of Diabetes & Vascular Disease, September 1, 2008; 8(5): 222 - 229. [Abstract] [PDF]
|
|
|
|
|
|
T. Saleem, K. H. Mohammad, M. M Abdel-Fattah, and A. H. Abbasi Association of glycosylated haemoglobin level and diabetes mellitus duration with the severity of coronary artery disease Diabetes and Vascular Disease Research, September 1, 2008; 5(3): 184 - 189. [Abstract] [PDF]
|
|
|
|
|
|
S.-H. Ko, S.-A. Park, J.-H. Cho, K.-H. Song, K.-H. Yoon, B.-Y. Cha, H.-Y. Son, K.-D. Yoo, K.-W. Moon, Y.-M. Park, et al. Progression of Cardiovascular Autonomic Dysfunction in Patients With Type 2 Diabetes: A 7-year follow-up study Diabetes Care, September 1, 2008; 31(9): 1832 - 1836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Shah Pioglitazone vs Glimepiride in the PERISCOPE Trial JAMA, August 20, 2008; 300(7): 787 - 788. [Full Text] [PDF]
|
|
|
|
|
|
H. C. Gerstein, K. Swedberg, J. Carlsson, J. J. V. McMurray, E. L. Michelson, B. Olofsson, M. A. Pfeffer, S. Yusuf, and for the CHARM Program Investigators The Hemoglobin A1c Level as a Progressive Risk Factor for Cardiovascular Death, Hospitalization for Heart Failure, or Death in Patients With Chronic Heart Failure: An Analysis of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program Arch Intern Med, August 11, 2008; 168(15): 1699 - 1704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Q. Nguyen, M. L. Maciejewski, S. Gao, E. Lin, B. Williams, and J. P. LoGerfo Health Care Use and Costs Associated With Use of a Health Club Membership Benefit in Older Adults with Diabetes Diabetes Care, August 1, 2008; 31(8): 1562 - 1567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. T. Cefalu Glycemic Targets and Cardiovascular Disease N. Engl. J. Med., June 12, 2008; 358(24): 2633 - 2635. [Full Text] [PDF]
|
|
|
|
|
|
The Action to Control Cardiovascular Risk in Diabe Effects of Intensive Glucose Lowering in Type 2 Diabetes N. Engl. J. Med., June 12, 2008; 358(24): 2545 - 2559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The ADVANCE Collaborative Group Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes N. Engl. J. Med., June 12, 2008; 358(24): 2560 - 2572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Simmons, S. Sharp, S. M. Boekholdt, L. A. Sargeant, K.-T. Khaw, N. J. Wareham, and S. J. Griffin Evaluation of the Framingham Risk Score in the European Prospective Investigation of Cancer-Norfolk Cohort: Does Adding Glycated Hemoglobin Improve the Prediction of Coronary Heart Disease Events? Arch Intern Med, June 9, 2008; 168(11): 1209 - 1216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Norris, D. Kansagara, C. Bougatsos, and R. Fu Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, June 3, 2008; 148(11): 855 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden Cardiovascular Disease in Diabetes Diabetes Care, June 1, 2008; 31(6): 1260 - 1266. [Full Text] [PDF]
|
|
|
|
|
|
N. Brewer, C. S. Wright, N. Travier, C. W. Cunningham, J. Hornell, N. Pearce, and M. Jeffreys A New Zealand Linkage Study Examining the Associations Between A1C Concentration and Mortality Diabetes Care, June 1, 2008; 31(6): 1144 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Boden-Albala, S. Cammack, J. Chong, C. Wang, C. Wright, T. Rundek, M. S.V. Elkind, M. C. Paik, and R. L. Sacco Diabetes, Fasting Glucose Levels, and Risk of Ischemic Stroke and Vascular Events: Findings from the Northern Manhattan Study (NOMAS) Diabetes Care, June 1, 2008; 31(6): 1132 - 1137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Campbell and J. R. White Jr More Choices Than Ever Before: Emerging Therapies for Type 2 Diabetes The Diabetes Educator, May 1, 2008; 34(3): 518 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Shirali and M. J. Bia Management of Cardiovascular Disease in Renal Transplant Recipients Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 491 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Milicevic, I. Raz, S. D. Beattie, B. N. Campaigne, S. Sarwat, E. Gromniak, I. Kowalska, E. Galic, M. Tan, and M. Hanefeld Natural History of Cardiovascular Disease in Patients With Diabetes: Role of hyperglycemia Diabetes Care, February 1, 2008; 31(Supplement_2): S155 - S160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bianchi, R. Miccoli, G. Penno, and S. Del Prato Primary Prevention of Cardiovascular Disease in People With Dysglycemia Diabetes Care, February 1, 2008; 31(Supplement_2): S208 - S214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Giugliano, A. Ceriello, and K. Esposito Glucose metabolism and hyperglycemia Am. J. Clinical Nutrition, January 1, 2008; 87(1): 217S - 222S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Hadler Oral Hypoglycemics and Diabetic Nephropathy Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 159 - 162. [Full Text] [PDF]
|
|
|
|
|
|
American Diabetes Association Standards of Medical Care in Diabetes--2008 Diabetes Care, January 1, 2008; 31(Supplement_1): S12 - S54. [Full Text] [PDF]
|
|
|
|
|
|
R. J. Sigal, G. P. Kenny, N. G. Boule, G. A. Wells, D. Prud'homme, M. Fortier, R. D. Reid, H. Tulloch, D. Coyle, P. Phillips, et al. Effects of Aerobic Training, Resistance Training, or Both on Glycemic Control in Type 2 Diabetes: A Randomized Trial Ann Intern Med, September 18, 2007; 147(6): 357 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. E. Kraus and B. D. Levine Exercise Training for Diabetes: The "Strength" of the Evidence Ann Intern Med, September 18, 2007; 147(6): 423 - 424. [Full Text] [PDF]
|
|
|
|
|
|
C. Day and C. J Bailey Glycaemic control IS important The British Journal of Diabetes & Vascular Disease, September 1, 2007; 7(5): 197 - 198. [PDF]
|
|
|
|
 |
|
 G. D. Harris A 52-Year-Old Woman With Hypertension and Diabetes Who Presents With Chest Pain Clin. Diabetes, July 1, 2007; 25(3): 115 - 118. [Full Text] [PDF]
|
|
|
|
|
|
K. Krzyzanowska, F. Mittermayer, M. Wolzt, and G. Schernthaner Asymmetric Dimethylarginine Predicts Cardiovascular Events in Patients With Type 2 Diabetes Diabetes Care, July 1, 2007; 30(7): 1834 - 1839. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74. [Full Text] [PDF]
|
|
|
|
|
|
P. Berikai, P. M. Meyer, R. Kazlauskaite, B. Savoy, K. Kozik, and L. Fogelfeld Gain in Patients' Knowledge of Diabetes Management Targets Is Associated With Better Glycemic Control Diabetes Care, June 1, 2007; 30(6): 1587 - 1589. [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Parchman, J. A. Pugh, R. L. Romero, and K. W. Bowers Competing Demands or Clinical Inertia: The Case of Elevated Glycosylated Hemoglobin Ann. Fam. Med, May 1, 2007; 5(3): 196 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Avogaro, C. Giorda, M. Maggini, E. Mannucci, R. Raschetti, F. Lombardo, S. Spila-Alegiani, S. Turco, M. Velussi, E. Ferrannini, et al. Incidence of Coronary Heart Disease in Type 2 Diabetic Men and Women: Impact of microvascular complications, treatment, and geographic location Diabetes Care, May 1, 2007; 30(5): 1241 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Snowling and W. G. Hopkins Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients: a Meta-Analysis: Response to Balducci et al. Diabetes Care, April 1, 2007; 30(4): e26 - e26. [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Myint, S. Sinha, N. J. Wareham, S. A. Bingham, R. N. Luben, A. A. Welch, and K.-T. Khaw Glycated Hemoglobin and Risk of Stroke in People Without Known Diabetes in the European Prospective Investigation Into Cancer (EPIC)-Norfolk Prospective Population Study: A Threshold Relationship? Stroke, February 1, 2007; 38(2): 271 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Buse, H. N. Ginsberg, G. L. Bakris, N. G. Clark, F. Costa, R. Eckel, V. Fonseca, H. C. Gerstein, S. Grundy, R. W. Nesto, et al. Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association Circulation, January 2, 2007; 115(1): 114 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J., January 1, 2007; 28(1): 88 - 136. [Full Text] [PDF]
|
|
|
|
|
|
J. B. Buse, H. N. Ginsberg, G. L. Bakris, N. G. Clark, F. Costa, R. Eckel, V. Fonseca, H. C. Gerstein, S. Grundy, R. W. Nesto, et al. Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A scientific statement from the American Heart Association and the American Diabetes Association Diabetes Care, January 1, 2007; 30(1): 162 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
American Diabetes Association Standards of Medical Care in Diabetes--2007 Diabetes Care, January 1, 2007; 30(suppl_1): S4 - S41. [Full Text] [PDF]
|
|
|
|
|
|
N. J. Snowling and W. G. Hopkins Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients: A meta-analysis. Diabetes Care, November 1, 2006; 29(11): 2518 - 2527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Ho, J. S. Rumsfeld, F. A. Masoudi, D. L. McClure, M. E. Plomondon, J. F. Steiner, and D. J. Magid Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med, September 25, 2006; 166(17): 1836 - 1841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Muntner, K. B. DeSalvo, R. P. Wildman, P. Raggi, J. He, and P. K. Whelton Trends in the Prevalence, Awareness, Treatment, and Control of Cardiovascular Disease Risk Factors among Noninstitutionalized Patients with a History of Myocardial Infarction and Stroke Am. J. Epidemiol., May 15, 2006; 163(10): 913 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden Cardiovascular Disease Diabetes Care, May 1, 2006; 29(5): 1160 - 1166. [Full Text] [PDF]
|
|
|
|
|
|
C. D. Saudek, R. L. Derr, and R. R. Kalyani Assessing Glycemia in Diabetes Using Self-monitoring Blood Glucose and Hemoglobin A1c JAMA, April 12, 2006; 295(14): 1688 - 1697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Soedamah-Muthu, J. H. Fuller, H. E. Mulnier, V. S. Raleigh, R. A. Lawrenson, and H. M. Colhoun High Risk of Cardiovascular Disease in Patients With Type 1 Diabetes in the U.K.: A cohort study using the General Practice Research Database Diabetes Care, April 1, 2006; 29(4): 798 - 804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Selvin, K. Wattanakit, M. W. Steffes, J. Coresh, and A. R. Sharrett HbA1c and Peripheral Arterial Disease in Diabetes: The Atherosclerosis Risk in Communities study Diabetes Care, April 1, 2006; 29(4): 877 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.R. Timmer, J.P. Ottervanger, H.J.G. Bilo, J.H.E. Dambrink, K. Miedema, J.C.A. Hoorntje, and F. Zijlstra Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromes QJM, April 1, 2006; 99(4): 237 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Dronge, M. F. Perkal, S. Kancir, J. Concato, M. Aslan, and R. A. Rosenthal Long-term Glycemic Control and Postoperative Infectious Complications Arch Surg, April 1, 2006; 141(4): 375 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Marso and W. R. Hiatt Peripheral Arterial Disease in Patients With Diabetes J. Am. Coll. Cardiol., March 7, 2006; 47(5): 921 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sander, C. Schulze-Horn, H. Bickel, H. Gnahn, E. Bartels, and B. Conrad Combined Effects of Hemoglobin A1c and C-Reactive Protein on the Progression of Subclinical Carotid Atherosclerosis: The INVADE Study Stroke, February 1, 2006; 37(2): 351 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Kennedy, W. H. Herman, P. Strange, A. Harris, and for the GOAL A1C Team Impact of Active Versus Usual Algorithmic Titration of Basal Insulin and Point-of-Care Versus Laboratory Measurement of HbA1c on Glycemic Control in Patients With Type 2 Diabetes: The Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial Diabetes Care, January 1, 2006; 29(1): 1 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
American Diabetes Association Standards of Medical Care in Diabetes-2006 Diabetes Care, January 1, 2006; 29(suppl_1): S4 - S42. [Full Text] [PDF]
|
|
|
|
|
|
W. T. Cefalu Glycemic Control and Cardiovascular Disease -- Should We Reassess Clinical Goals? N. Engl. J. Med., December 22, 2005; 353(25): 2707 - 2709. [Full Text] [PDF]
|
|
|
|
|
|
L. Wartofsky Update in Endocrinology Ann Intern Med, November 1, 2005; 143(9): 673 - 682. [Full Text] [PDF]
|
|
|
|
|
|
D. T. Eurich, S. R. Majumdar, F. A. McAlister, R. T. Tsuyuki, and J. A. Johnson Improved Clinical Outcomes Associated With Metformin in Patients With Diabetes and Heart Failure Diabetes Care, October 1, 2005; 28(10): 2345 - 2351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chodosh, S. C. Morton, W. Mojica, M. Maglione, M. J. Suttorp, L. Hilton, S. Rhodes, and P. Shekelle Meta-Analysis: Chronic Disease Self-Management Programs for Older Adults Ann Intern Med, September 20, 2005; 143(6): 427 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Selvin, J. Coresh, S. H. Golden, F. L. Brancati, A. R. Folsom, and M. W. Steffes Glycemic Control and Coronary Heart Disease Risk in Persons With and Without Diabetes: The Atherosclerosis Risk in Communities Study Arch Intern Med, September 12, 2005; 165(16): 1910 - 1916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Muntner, R. P. Wildman, K. Reynolds, K. B. DeSalvo, J. Chen, and V. Fonseca Relationship Between HbA1c Level and Peripheral Arterial Disease Diabetes Care, August 1, 2005; 28(8): 1981 - 1987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Other articles noted Evid. Based Med., June 1, 2005; 10(3): 95 - 96. [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Bunt, P. A. Tataranni, and A. D. Salbe Intrauterine Exposure to Diabetes Is a Determinant of Hemoglobin A1c and Systolic Blood Pressure in Pima Indian Children J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3225 - 3229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J Sigal Haemoglobin A1c concentrations were associated with increased cardiovascular disease and all cause mortality Evid. Based Med., April 1, 2005; 10(2): 57 - 57. [Full Text] [PDF]
|
|
|
|
|
|
American Diabetes Association Standards of Medical Care in Diabetes Diabetes Care, January 1, 2005; 28(suppl_1): S4 - S36. [Full Text] [PDF]
|
|
|
|
 |
|
 Elevated Blood Sugar: Apparent Cardiac Risk Factor Journal Watch Cardiology, December 31, 2004; 2004(1231): 3 - 3. [Full Text]
|
|
|
|
|
|
Elevated Blood Sugar: Apparent Cardiac Risk Factor Journal Watch Cardiology, November 5, 2004; 2004(1105): 1 - 1. [Full Text]
|
|
|
|
 |
|
 Dysglycemia: A New Cardiac Risk Factor? Journal Watch (General), October 8, 2004; 2004(1008): 2 - 2. [Full Text]
|
|
|
|
 |
|
 In brief BMJ, September 25, 2004; 329(7468): 700 - 700. [Full Text] [PDF]
|
|
|
|
|
|
H. C. Gerstein Glycosylated Hemoglobin: Finally Ready for Prime Time as a Cardiovascular Risk Factor Ann Intern Med, September 21, 2004; 141(6): 475 - 476. [Full Text] [PDF]
|
|
